Invivo Therapeutics Holdings Corp (NVIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVIV | ABT | SYK | BSX | MDT |
| Company | Invivo Therapeutics Holdings Corp | Abbott Laboratories | Stryker Corp | Boston Scientific Corp | Medtronic Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 0.4081 | 118.28 | 386.29 | 89.69 | 86.50 |
| High | 0.4090 | 118.65 | 388.43 | 90.30 | 86.83 |
| Low | 0.3010 | 117.58 | 379.50 | 87.95 | 84.77 |
| Last | 0.3207 | 117.94 | 381.58 | 88.74 | 85.50 |
| Change | -0.1673 | +0.18 | -3.27 | -1.26 | -0.71 |
| % Change | -34.28% | +0.15% | -0.85% | -1.40% | -0.82% |
| Volume | 1,885,600 | 1,330,441 | 596,365 | 2,272,032 | 2,829,016 |
| 20-Day Average Volume | 11,541,605 | 5,253,156 | 1,469,634 | 6,067,705 | 6,793,235 |
| Previous Close | 0.4880 | 117.76 | 384.85 | 90.00 | 86.21 |
| Industry | Medical Products | Medical Products | Medical Products | Medical Products | Medical Products |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5823 | 116.37 | 377.29 | 87.51 | 87.82 |
| 20-Day Raw Stochastic | 11.92% | 66.41% | 63.65% | 75.29% | 25.06% |
| 20-Day Relative Strength | 37.35% | 56.18% | 57.51% | 58.16% | 42.61% |
| Weighted Alpha | -67.27 | +13.30 | +27.57 | +55.63 | +5.70 |
| Today's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 24% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 40% Buy |
| Last Month's Opinion | 64% Sell | 56% Buy | 40% Buy | 80% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +44.46% since 02/05/24 | +0.67% since 11/18/24 | -1.92% since 11/18/24 | -1.45% since 11/18/24 | -2.19% since 11/18/24 |
| Low | 0.3010 on 02/12/24 | 115.14 on 11/21/24 | 379.50 on 11/25/24 | 87.95 on 11/25/24 | 83.55 on 11/20/24 |
| High | 1.0500 on 02/06/24 | 118.59 on 11/25/24 | 392.30 on 11/19/24 | 91.93 on 11/22/24 | 86.80 on 11/25/24 |
| 1-Month | |||||
| %Chg | -58.69% since 01/12/24 | +3.44% since 10/25/24 | +8.25% since 10/25/24 | +5.20% since 10/25/24 | -5.43% since 10/25/24 |
| Low | 0.2220 on 02/05/24 | 112.50 on 10/30/24 | 353.45 on 10/29/24 | 80.64 on 10/30/24 | 83.55 on 11/20/24 |
| High | 1.0500 on 02/06/24 | 121.00 on 11/06/24 | 398.20 on 11/18/24 | 91.93 on 11/22/24 | 92.03 on 11/06/24 |
| 3-Month | |||||
| %Chg | -57.24% since 11/10/23 | +4.84% since 08/23/24 | +8.11% since 08/23/24 | +12.59% since 08/23/24 | -3.03% since 08/23/24 |
| Low | 0.2220 on 02/05/24 | 111.68 on 10/04/24 | 343.95 on 10/07/24 | 78.90 on 08/26/24 | 83.55 on 11/20/24 |
| High | 1.0500 on 02/06/24 | 121.00 on 11/06/24 | 398.20 on 11/18/24 | 91.93 on 11/22/24 | 92.68 on 10/24/24 |
| 6-Month | |||||
| %Chg | -74.75% since 08/11/23 | +13.66% since 05/24/24 | +13.83% since 05/24/24 | +17.86% since 05/24/24 | +4.11% since 05/24/24 |
| Low | 0.2220 on 02/05/24 | 99.71 on 07/18/24 | 314.93 on 08/05/24 | 71.88 on 08/05/24 | 75.96 on 07/09/24 |
| High | 1.3099 on 08/25/23 | 121.00 on 11/06/24 | 398.20 on 11/18/24 | 91.93 on 11/22/24 | 92.68 on 10/24/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 996 | 204,249,424 | 146,710,976 | 132,644,432 | 110,561,480 |
| Shares Outstanding, K | 3,105 | 1,734,455 | 381,216 | 1,473,827 | 1,282,467 |
| Annual Sales | 0 | 40,109,000,000 | 20,498,000,000 | 14,240,000,000 | 32,364,000,000 |
| Annual Net Income | -10,490,000 | 5,723,000,000 | 3,165,000,000 | 1,591,000,000 | 3,677,000,000 |
| Last Quarter Sales | 0 | 10,635,000,000 | 5,494,000,000 | 4,209,000,000 | 7,915,000,000 |
| Last Quarter Net Income | -2,700,000 | 1,646,000,000 | 834,000,000 | 468,000,000 | 1,043,000,000 |
| 60-Month Beta | 0.65 | 0.72 | 0.91 | 0.79 | 0.84 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.87 on 11/08/23 | 1.21 on 10/16/24 | 2.87 on 10/29/24 | 0.63 on 10/23/24 | 1.26 on 11/19/24 |
| Latest Earnings Date | 02/14/24 | 10/16/24 | 10/29/24 | 10/23/24 | 11/19/24 |
| Most Recent Dividend | N/A | 0.550 on 10/15/24 | 0.800 on 09/30/24 | N/A | 0.700 on 09/27/24 |
| Next Ex-Dividends Date | N/A | 10/15/24 | 09/30/24 | N/A | 09/27/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.94 | 33.52 | 38.77 | 16.14 |